All Articles

A Canadian firm hits record gas production in Uzbekistan, hailing a repeatable success model. But can it balance fossil fuel growth with its 'energy transition' identity?

A new 891-acre luxury enclave is launching in Carmel with $6M+ homes. We unpack the project's complex history, its global financial backing, and what it signals.

Alto Neuroscience's $100M raise fuels its quest to treat resistant depression. It's a high-stakes play on a biomarker-driven approach in a challenging field.

In a fluctuating private aviation market, Northern Jet's hiring of Ken Price signals a wider industry trend: human expertise is the ultimate asset.

As BNB Plus Corp. falls from Nasdaq to the over-the-counter markets, its hybrid crypto-biotech model is under intense scrutiny. What does this mean for investors?

Atlas launches its new AI platform, promising to turn weeks of research into hours by blending agentic AI with crucial human review for strategic insights.

A partnership between Stretch Zone and Hint water is more than a summer promo. It's a look into the future of integrated, resilient wellness systems.

In a major leadership transition, ViaQuest names 19-year veteran Emily Stickley as CEO. Her promotion, alongside a new CFO, signals a focus on continuity.

NUBURU is launching a bold, premium-priced $38M offering to acquire Tekne, clear its books, and secure its NYSE listing in a high-stakes pivot to defense.

Comvest Private Equity is now Vesterra Capital Partners. This isn't a pivot, but a strategic sharpening of its operational playbook in a crowded market.

While headlines celebrate easing inflation at 3.9%, stubborn services costs reveal a deeper battle, challenging the Fed's final push to its 2% target.

A landmark alliance brings data-driven skill tracking and on-site sports to 10,000 preschools, tackling Japan's deep-seated childcare industry woes.

A star-studded concert in Latvia wasn't just a party. It was a masterclass in soft power, revealing the invisible infrastructure of security and private capital.

A Utah biotech is deploying UAE genomics and a novel drug to mimic natural immunity to Alzheimer's, signaling a strategic shift to precision prevention.

McDermott Will & Schulte's hire of a top PE lawyer isn't just a personnel move. It's the capstone of a decade-long strategy to conquer New York.

The appointment of Irvinder Singh Lail signals a strategic shift, aiming to unify global talent and AI to master the complex, high-stakes consulting market.

Chesapeake Utilities is doubling down on the Sunshine State with a massive natural gas pipeline. But is this $1.2 billion project a masterstroke or a risky gamble?

An exclusive deal makes high-resolution aerial imagery a new global standard, embedding a single source of truth into the systems that run our cities.

Ocugen inks a potential $255M+ deal to bring its OCU400 gene therapy for Retinitis Pigmentosa to the MENA region, a strategic move into a high-need market.

Fresh from a 2020 bankruptcy, the menswear giant behind Men's Wearhouse is going public. Can it convince Wall Street that suits and stores have a future?